Sign up
Pharma Capital

Collagen Solutions' Jamal Rushdy hails 'significant' growth in Asia-Pacific & Europe

Jamal Rushdy, chief executive of Collagen Solutions PLC (LON:COS) talks through the firm's results for the year to the end of March 2017.


View full COS profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.